leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Media > Recent and Archival
April 18, 2014

Boulder: Sixth and Seventh Subjects Treated, Amendment Submitted to FDA and IRB

On April 18, 2014, the sixth subject was treated in our ongoing study of MDMA-assisted psychotherapy for PTSD in Boulder, Colorado. The seventh subject was enrolled on March 27, and received the first MDMA-assisted psychotherapy session on May 2. Additionally, on May 1, we submitted a revised protocol for review to the Institutional Review Board proposing to increase the study size from 17 to 23 subjects , and on May 2 we submitted the revised protocol to the U.S. Food and Drug Administration. This study is investigating the safety and effectiveness of MDMA-assisted psychotherapy for subjects with chronic, treatment-resistant PTSD resulting from sexual assault, violent crime, war, or any other cause.

Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.